TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant glioma
Bastian Zinnhardt(Roche (Switzerland)), Oliver Grauer(University Hospital Münster), Wolfgang Roll(University Hospital Münster), Matthias Weckesser(University Hospital Münster), Philipp Backhaus(German Cancer Research Center), Heinz Wiendl(University Medical Center Freiburg), Astrid Jeibmann(University Hospital Münster), Cristina Barca(University of Münster), Sven Hermann(University of Münster), Michael Müther, Walter Stummer(University of Münster), Bertrand Tavitian(Inserm), Alexandra Winkeler(Centre National de la Recherche Scientifique), Stefan Wagner(University Hospital Münster), Andreas H. Jacobs(University of Münster), Christian Döring(University of Münster), Claudia Foray(University of Münster), Frédéric Dollé(Inserm), Michael Schäfers(Blackberry (United States))
Cited by 68
Related Papers
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k
Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients
|Journal of neurosurgery|2000|880
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Ofatumumab versus Teriflunomide in Multiple Sclerosis
|New England Journal of Medicine|2020|706